Gastrointestinal dysfunction has important implications for plasma L-dopa concentrations in Parkinson's disease

Clinical Neurology

Volumn 53, Issue 11, 2013, Pages 1382-1385

  Doi, Hirokazu ^a   Sakakibara, Ryuji ^a   Kishi, Masahiko ^a   Tsuyuzaki, Yohei ^a   Tateno, Fuyuki ^a   Hirai, Shigekazu ^a  

^a TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

Author keywords

Autonomic failure; Gastric emptying; L dopa; Non motor symptom; Parkinson's disease

Indexed keywords

DOPAMINE 2 RECEPTOR BLOCKING AGENT; HERBACEOUS AGENT; LEVODOPA; RIKKUNSHI TO; SEROTONIN 4 AGONIST; UNCLASSIFIED DRUG;

ARTICLE; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRACT; HERBAL MEDICINE; HUMAN; PARKINSON DISEASE; POSTGANGLIONIC NERVE; STOMACH EMPTYING;

ANTIPARKINSON AGENTS; AUTONOMIC NERVOUS SYSTEM DISEASES; DRUG TOLERANCE; DRUGS, CHINESE HERBAL; GASTRIC EMPTYING; GASTROINTESTINAL DISEASES; HUMANS; LEVODOPA; PARKINSON DISEASE; PHYTOTHERAPY;

EID: 84891802003     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.53.1382     Document Type: Article

References (10)

1. Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
2. Wakabayashi K, Takahashi H. Neuropathology of autonomic nervous system in Parkinson's disease. Eur Neurol 1997;38:2-7.
3. Edwards LL, Pfeiffer RF, Quigley EM, et al. Gastrointestinal symptoms in Parkinson's disease. Mov Disord 1991;6:151-156.
4. Tanaka Y, Kato T, Nishida H, et al. Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson's disease? An analysis using the 13C-acetate breath test. J Neurol 2011;258:421-426.
5. Abbott RD, Petrovitch H, White LR, et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001;57:456-462.
6. Doi H, Sakakibara R, Sato M, et al. Plasma levodopa peak delay and impaired gastric emptying in Parkinson's disease. J Neurol Sci 2012;319:86-88.
7. Asai H, Udaka F, Hirano M, et al. Increased gastric motility during 5-HT4 agonist therapy reduces response fluctuations in Parkinson's disease. Parkinsonism Relat Disord 2005;11:499-502.
8. Hiyama Y, Tosa H, Terasawa K, et al. The effects of Rikkunshi-to on Parkinsonian patients with unstable effect of levodopa/carbidopa. 1991;8:83-88.
9. Hansen MB. Neurohumoral control of GI motility. Physiol Res 2003;52:1-30.